U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2013
596
Name Type Language
OBINUTUZUMAB
DASH   INN   MART.   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
OBINUTUZUMAB [MI]
Common Name English
AFUTUZUMAB
Common Name English
RO5072759
Code English
OBINUTUZUMAB [MART.]
Common Name English
HUMABCD20
Common Name English
OBINUTUZUMAB [USAN]
Common Name English
RG-7159
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
Common Name English
RO-5072759 HUMAB CD20
Code English
OBINUTUZUMAB [JAN]
Common Name English
OBINUTUZUMAB [VANDF]
Common Name English
GAZYVA
Brand Name English
OBINUTUZUMAB [PURPLE BOOK CDER]
Common Name English
Obinutuzumab [WHO-DD]
Common Name English
GA101
Code English
obinutuzumab [INN]
Common Name English
RO-5072759
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
Common Name English
HUMAB CD20
Code English
GAZYVARO
Brand Name English
GA-101
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 473315
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
WHO-ATC L01XC15
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
EU-Orphan Drug EU/3/14/1325
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 727719
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 889422
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
NCI_THESAURUS C141215
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 824921
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
NDF-RT N0000175657
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 592717
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 473415
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 360011
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
EMA ASSESSMENT REPORTS GAZYVARO (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
FDA ORPHAN DRUG 359911
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
WHO-VATC QL01XC15
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
Code System Code Type Description
RXCUI
974779
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m11722
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
SMS_ID
100000125968
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
DRUG BANK
DB08935
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
HSDB
8249
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
IUPHAR
6941
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
NCI_THESAURUS
C70741
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
DRUG CENTRAL
4983
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
USAN
UU-119
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
FDA UNII
O43472U9X8
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
WIKIPEDIA
OBINUTUZUMAB
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
LACTMED
Obinutuzumab
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
INN
9043
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
EVMPD
SUB32751
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
ChEMBL
CHEMBL1743048
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
CAS
949142-50-1
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
DAILYMED
O43472U9X8
Created by admin on Sat Dec 16 16:30:40 GMT 2023 , Edited by admin on Sat Dec 16 16:30:40 GMT 2023
PRIMARY
ACTIVE MOIETY
OBINUTUZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966